שימוש בתרכובת tetrasubstituted pyrazolo[4,3–d]pyrimidine לטיפול בנוירופטיה סכרתית

• 收藏
• 分享

专利权人:

NIHAD TAMIMI;PFIZER INC.;JEREMY GALE;VALERIE CLERIN

发明人:

申请号：

IL23837415

公开号：

IL238374D0

申请日:

2015.04.19

申请国别(地区):

IL

年份:

2015

代理人:

摘要：

The present invention relates to methods of delaying progression to end stage renal disease (ESRD) in patients comprising administration of 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methyl-pyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide. The present invention also includes administration of pharmaceutical compositions for delaying progression to ESRD. 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methyl-pyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/